Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders
Sponsor: Denver Health and Hospital Authority
A NA clinical study on Opioid Abuse and Overdose, this trial is completed. The trial is conducted by Denver Health and Hospital Authority and has accumulated 13 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2022 — Sep 2023 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Mar 2022 [monthly]
Active Not Recruiting NA
▶ Show 8 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Nov 2018 — Nov 2019 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Nov 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Denver Health and Hospital Authority
- Kaiser Permanente
- National Institute on Drug Abuse (NIDA)
For direct contact, visit the study record on ClinicalTrials.gov .